THE DUBERSTEIN GROUP INC.

Biopharma

Latest filing Jul 20, 2026

Consulting

$3.1M

Reported income

Health Issues leads by disclosed activity

Filings

Most recent on Jul 20, 2026

Clients represented

MAJOR LEAGUE BASEBALL leads by reported income

Lobbyists employed

BENJAMIN R HOWARD appears most prominently

$107.1K

Contribution spend

Thomas Roland Tillis leads among recipients

Reported Income Over Time

Annual totals based on disclosed filing amounts.

2026

$3.1M50 filings

Client Portfolio

The clients this firm represents, ranked by disclosed filing amounts.

MAJOR LEAGUE BASEBALL

Gaming & Entertainment

2 filingsLatest Jul 20, 2026

Professional sports league.

$200K

GILEAD SCIENCES, INC.

Biopharma

2 filingsLatest Jul 20, 2026

Biotechnology company that researches, develops and commercializes drugs.

$180K

What They Lobby On

Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.

Health Issues

HCR

9 mentions9 filingsLatest Jul 20, 2026

$464.2K

apportioned income

HOUSE OF REPRESENTATIVES8White House Office6SENATE5Health & Human Services, Dept of (HHS)2

Government Touchpoints

The entities named in disclosed activities are the clearest available signal for where the firm is directing attention.

01HOUSE OF REPRESENTATIVES

58 mentions

02SENATE

42 mentions

03White House Office

30 mentions

04Energy, Dept of

5 mentions

Contribution Recipients

Officials who received contribution dollars disclosed by this firm.

Total contributions

$107.1K

Contribution items

Officials reached

01Thomas Roland Tillis

Senator • North Carolina

$10.5K

3 items

02Frank Pallone

Representative • New Jersey

Industry Profile

AI-classified industry allocation based on the firm's filing activity.

Confidence

39%

Industry count

Biopharma

12%

Transportation

11%

Technology

11%

Consumer & Retail

Recent Filings

The latest disclosures filed by this firm.

CATERPILLAR INCQ2

2026 second quarter1 issues3 lobbyists

$100K

Jul 20, 2026

INTUIT, INC. AND AFFILIATES (FORMERLY INTUIT, INC.)Q2

2026 second quarter1 issues2 lobbyists

Financial Institutions/Investments/Securities

THE DUBERSTEIN GROUP INC.

Reported Income Over Time

Client Portfolio

What They Lobby On

Health Issues

Government Touchpoints

Contribution Recipients

Industry Profile

Recent Filings

Lobbyists Employed

Trade (domestic/foreign)

Energy/Nuclear

Sports/Athletics

Taxation/Internal Revenue Code

Manufacturing

Copyright/Patent/Trademark

Science/Technology